Treatment Selection in First-line Metastatic Renal Cell Carcinoma—The Contemporary Treatment Paradigm in the Age of Combination Therapy
Author:
Affiliation:
1. Medical Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada
Publisher
American Medical Association (AMA)
Subject
Oncology,Cancer Research
Link
https://jamanetwork.com/journals/jamaoncology/articlepdf/2786404/jamaoncology_navani_2021_rv_210011_1637168408.85971.pdf
Reference75 articles.
1. Comprehensive molecular characterization of clear cell renal cell carcinoma.;Cancer Genome Atlas Research Network;Nature,2013
2. Oncology meets immunology: the cancer-immunity cycle.;Chen;Immunity,2013
3. Sorafenib in advanced clear-cell renal-cell carcinoma.;Escudier;N Engl J Med,2007
4. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy.;Havel;Nat Rev Cancer,2019
5. Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma.;Quesada;J Clin Oncol,1985
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database Consortium;ESMO Open;2024-07
2. Case report: Report of a rare encounter: metastasis of renal cell carcinoma to the thyroid;Frontiers in Oncology;2024-04-23
3. Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma;Expert Review of Precision Medicine and Drug Development;2024-03-18
4. Next‑generation sequencing‑guided personalized therapy in renal cell carcinoma;Holistic Integrative Oncology;2024-02-05
5. Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis;Pathology - Research and Practice;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3